About
Therapeutic Focus
Technology
News
Career
English
Français
About
Therapeutic Focus
Technology
News
Career
English
Français
Search
Menu
About
Therapeutic Focus
Technology
News
Career
Feldan News
FELDAN ANNOUNCES APPOINTMENT OF ELISABETH SANDOVAL LITTLE, NATHALIE CHAURET AND ANGIE JIWON CHUN TO BOARD OF DIRECTORS
FELDAN ANNOUNCES A PUBLICATION IN NATURE COMMUNICATIONS
FELDAN THERAPEUTICS APPOINTS DAVID J. MAZZO, PH.D. CHAIRMAN OF THE BOARD OF DIRECTORS
FELDAN THERAPEUTICS ANNOUNCES APPOINTMENT OF DR. KENNETH KOBAYASHI AS CHIEF MEDICAL OFFICER
FELDAN IS AWARDED A GRANT FROM THE NATIONAL RESEARCH COUNCIL CANADA (NCR-IRAP)
FELDAN IS AWARDED A GRANT FROM THE NATIONAL SCIENCES AND ENGINEERING RESEARCH COUNCIL OF CANADA
FELDAN THERAPEUTICS SECURES $16.5M SERIES B TO BRING LEAD ASSET TO CLINICAL DEVELOPMENT
CQDM, FELDAN THERAPEUTICS AND AMGEN FUND DEVELOPMENT OF INNOVATIVE DRUG DELIVERY TECHNOLOGY TO TARGET LUNG DISEASES
PROMISING RESULTS OF FLD103 TO TREAT BASAL CELL CARCINOMA
FELDAN THERAPEUTICS AWARDED FUNDING BY CYSTIC FIBROSIS FOUNDATION
FELDAN FEATURED IN THE SPRING 2021 EDITION OF BIOTECANADA'S INSIGHTS MAGAZINE
FELDAN CONGRATULATES SCGE PROGRAM FOR NATURE ARTICLE
FELDAN THERAPEUTICS APPOINTS DAVID J. MAZZO, PH.D. AND IAIN D. DUKES, PH.D. TO BOARD OF DIRECTORS
FELDAN THERAPEUTICS FORMS A SCIENTIFIC ADVISORY BOARD AND EXPANDS ITS LEADERSHIP TEAM
FELDAN THERAPEUTICS APPOINTS DR ROBERT J. WILLS TO BOARD OF DIRECTORS
FELDAN THERAPEUTICS ANNOUNCES A PUBLICATION IN NATURE COMMUNICATIONS
FELDAN THERAPEUTICS HONORED AT THE 2019 ANGES QUÉBEC ANNUAL RENDEZ-VOUS
AMGEN AND TAKEDA JOIN THE QUANTUM LEAP PROJECT LED BY CQDM AND FELDAN THERAPEUTICS, TO IMPROVE A NOVEL INTRACELLULAR DELIVERY TECHNOLOGY
NEW CORPORATE IDENTITY FOR FELDAN THERAPEUTICS
FRANCOIS-THOMAS MICHAUD RECIPIENT OF THE VISIONARY ENTREPRENEUR OF THE YEAR AWARD
FELDAN THERAPEUTICS ANNOUNCES ADDITIONAL INVESTMENT IN SERIES A
FELDAN THERAPEUTICS IS PROUD TO SUPPORT THE 2019TH EDITION OF THE ANNUAL CRISPR CONFERENCE
UNIVERSITY OF IOWA AND FELDAN THERAPEUTICS AWARDED GRANT BY THE NATIONAL INSTITUTES OF HEALTH
FELDAN THERAPEUTICS RAISES $12.5 MILLION IN SERIES A FINANCING ROUND
GC LABCELL AND FELDAN THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP NEXT-GENERATION NK CELLS FOR IMMUNOTHERAPY USING FELDAN SHUTTLE TECHNOLOGY
FELDAN IS ATTENDING BIO INTERNATIONAL CONVENTION, JUNE 4-7 2018 IN BOSTON, USA.
FELDAN THERAPEUTICS AWARDED US PATENT FOR THE SECOND GENERATION OF ITS FELDAN SHUTTLE PLATFORM
FELDAN AT TIDES 2018
FELDAN THERAPEUTICS AT RESI 2018 (TORONTO)
READ THE LATEST ON FELDAN SHUTTLE TECHNOLOGY
CQDM WILL PARTNER WITH FELDAN TO SUPPORT A $1.2M PROJECT
FELDAN THERAPEUTICS WILL BE ATTENDING THE INNATE KILLER SUMMIT 2018
READ THE LATEST ON FELDAN SHUTTLE TECHNOLOGY
FELDAN THERAPEUTICS AND GREENCROSS LABCELL ANNOUNCE START OF JOINT COLLABORATION
FELDAN THERAPEUTICS ANNOUNCES INSSUANCE OF FIRST PATENT FOR ITS PEPTIDE-BASED PROTEIN DELIVERY TECHNOLOGY, THE FELAN SHUTTLE
FELDAN THERAPEUTICS WILL BE ATTENDING THE BIO INTERNATIONAL CONVENTION 2017
FELDAN THERAPEUTICS & ELASMOGEN
Recent
Archive
January 2018
(2)
March 2018
(2)
April 2018
(2)
May 2018
(2)
June 2018
(2)
November 2018
(2)
June 2019
(2)
April 2021
(2)
June 2023
(2)
August 2023
(2)
September 2016
(1)
April 2017
(1)
August 2017
(1)
September 2018
(1)
October 2018
(1)
December 2018
(1)
February 2019
(1)
October 2019
(1)
June 2020
(1)
January 2021
(1)
February 2021
(1)
January 2022
(1)
March 2023
(1)
April 2023
(1)
October 2023
(1)
December 2023
(1)
February 2024
(1)
More...
